A carregar...
Biosimilars in inflammatory bowel disease: A review of post-marketing experience
Biologic compounds are obtained from living organisms or cell cultures by means of biotechnology methods. A similar biologic drug, commonly called biosimilar, is a product copied by a native approved biologic drug whose license has expired. Biosimilar drugs usually are marketed at a lower price and...
Na minha lista:
Publicado no: | World J Gastroenterol |
---|---|
Main Authors: | , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Baishideng Publishing Group Inc
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5236499/ https://ncbi.nlm.nih.gov/pubmed/28127193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v23.i2.197 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|